EGCG enhances the efficacy of cisplatin by downregulating hsa-miR-98-5p in NSCLC A549 cells.
about
MicroRNA-98 rescues proliferation and alleviates ox-LDL-induced apoptosis in HUVECs by targeting LOX-1Regulation of microRNAs by natural agents: new strategies in cancer therapies.EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary CancerThe green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.How Diet Intervention via Modulation of DNA Damage Response through MicroRNAs May Have an Effect on Cancer Prevention and Aging, an in Silico Study.In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity.NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells.The bounty of nature for changing the cancer landscape.Anticancer Natural Compounds as Epigenetic Modulators of Gene ExpressionDietary Intervention by Phytochemicals and Their Role in Modulating Coding and Non-Coding Genes in Cancer.Modulation of microRNAs by phytochemicals in cancer: underlying mechanisms and translational significance.Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancer.Molecular Mechanisms and Pathways as Targets for Cancer Prevention and Progression with Dietary Compounds.MicroRNA-125a-3p downregulation correlates with tumorigenesis and poor prognosis in patients with non-small cell lung cancer.Role of phytochemicals in the modulation of miRNA expression in cancer.MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas.[Effect of Chemical Prevention Drugs-based MicroRNAs and Their Target Genes on Tumor Inhibition].
P2860
Q33724036-F7C71F1B-1DF6-428E-A735-5AD31F86AD3CQ34194495-494D0C33-68D9-4942-99BD-721FE6B926BAQ35558444-BAF36671-B527-44AF-8E11-C7B7C679834AQ35671261-FFA90669-F25D-435D-BA3C-D2CDA7069ED2Q36939317-92F676D5-2FB7-45F4-B564-779C02DA4B3EQ37044525-C761CEB8-6E17-4FB5-B108-EE0A48B495E4Q37536566-A9504D61-8423-4A4F-9936-8D3557C8CDE4Q38707912-F1EECACC-D40B-4A5D-A5F4-3CED0305DDDCQ39214234-04B627FB-7457-4608-B5B0-32B7ED28E561Q39354574-004BF214-DDF3-4FE1-88A4-6EA46D8FB66DQ42180647-1B7A2E1C-4A8A-4829-AD18-B63481020302Q46227416-A2683509-65F9-4FFA-AE71-006126A6787DQ46300890-682044F5-0063-41EB-B9BA-732D502BB710Q47174743-E9F4D944-C4E1-478B-8EE7-685BF163BB8DQ47984355-CA64BEA2-D8B1-4371-AF3E-4EBD326AECD7Q49409530-02A62083-0266-415C-BF80-7752B8935A16Q55504620-F7367813-E252-4633-888A-292EEB3683EE
P2860
EGCG enhances the efficacy of cisplatin by downregulating hsa-miR-98-5p in NSCLC A549 cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
EGCG enhances the efficacy of ...... miR-98-5p in NSCLC A549 cells.
@en
EGCG enhances the efficacy of ...... miR-98-5p in NSCLC A549 cells.
@nl
type
label
EGCG enhances the efficacy of ...... miR-98-5p in NSCLC A549 cells.
@en
EGCG enhances the efficacy of ...... miR-98-5p in NSCLC A549 cells.
@nl
prefLabel
EGCG enhances the efficacy of ...... miR-98-5p in NSCLC A549 cells.
@en
EGCG enhances the efficacy of ...... miR-98-5p in NSCLC A549 cells.
@nl
P2093
P2860
P1433
P1476
EGCG enhances the efficacy of ...... miR-98-5p in NSCLC A549 cells.
@en
P2093
Dong-Hu Zhou
Xuemin Wang
P2860
P304
P356
10.1080/01635581.2014.894101
P577
2014-04-08T00:00:00Z